$14.96
1.9214.72%
At Close: -
$14.65
-0.31-2.07%
After Hours: 7:31 PM EDT
15 minutes delayed
KalVista Pharma
KALVNASDAQ
KalVista Pharma (NASDAQ:KALV) Stock, Insider Trading Activity
KalVista Pharma: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are KalVista Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for KalVista Pharmaceuticals Inc
Institutional Shares Held
10.371M
Institutional Percentage Held
24.6%
| Jun 10, 2024 | Benjamin L Palleiko | CHIEF EXECUTIVE OFFICER | 8.16K | $11.53 | -$86.07K | SELL-OPTIONS | 3.77% | 224.55K | Jun 06 - Jun 07 | View |
| May 21, 2024 | Edward Feener | CHIEF SCIENTIFIC OFFICER | 10.70K | $11.76 | -$95.15K | SELL-OPTIONS | 17.22% | 72.86K | May 17 - May 20 | View |
| May 21, 2024 | Paul Audhya | CHIEF MEDICAL OFFICER | 17.44K | $11.76 | -$155.00K | SELL-OPTIONS | 32.97% | 70.33K | May 17 - May 20 | View |
| May 21, 2024 | Benjamin L Palleiko | CHIEF EXECUTIVE OFFICER | 29.07K | $11.76 | -$258.34K | SELL-OPTIONS | 15.52% | 216.39K | May 17 - May 20 | View |
| May 21, 2024 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 7.18K | $11.76 | -$136.59K | SELL-OPTIONS | 9.85% | 80.07K | May 17 - May 20 | View |
| Feb 21, 2024 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -9.50K | $14.07 | -$397.93K | SELL | -13.26% | 62.16K | Feb 17 - Feb 20 | View |
| Feb 21, 2024 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 6.74K | $14.11 | -$170.12K | SELL-OPTIONS | 10.18% | 72.89K | Feb 17 - Feb 20 | View |
| Feb 21, 2024 | Benjamin L Palleiko | CFO, CBO | 28.23K | $14.11 | -$321.85K | SELL-OPTIONS | 17.74% | 187.31K | Feb 17 - Feb 20 | View |
| Feb 21, 2024 | Paul Audhya | CHIEF MEDICAL OFFICER | 16.32K | $14.12 | -$201.77K | SELL-OPTIONS | 44.62% | 52.89K | Feb 17 - Feb 20 | View |
| Feb 21, 2024 | Andrew Thomas Crockett | CEO | 29.53K | $14.11 | -$351.29K | SELL-OPTIONS | 16.25% | 211.20K | Feb 17 - Feb 20 | View |
| Feb 16, 2024 | Benjamin L Palleiko | CFO, CBO | -40.85K | $15.01 | -$613.20K | SELL | -20.43% | 159.09K | Feb 14 | View |
| Feb 16, 2024 | Andrew Thomas Crockett | CEO | -58.36K | $15.01 | -$875.88K | SELL | -24.31% | 181.68K | Feb 14 | View |
| Feb 16, 2024 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -28.17K | $15.01 | -$422.83K | SELL | -28.22% | 71.66K | Feb 14 | View |
| Feb 16, 2024 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | -39.89K | $15.01 | -$598.66K | SELL | -37.61% | 66.16K | Feb 14 | View |
| Feb 08, 2024 | Venrock Healthcare Capital Partners III LPBong KohVHCP CoInvestment Holdings III LLCVHCP Management III LLCVHCP Management EG LLCVenrock Healthcare Capital Partners EG LPNimish Shah | 10% OWNER | 86.05K | $14.62 | $1.26M | BUY | 1.82% | 4.82M | Feb 06 - Feb 08 | View |
| Feb 05, 2024 | Andrew Thomas Crockett | CEO | -10.00K | $16.22 | -$162.20K | SELL | -7.84% | 117.53K | Feb 01 | View |
| Feb 01, 2024 | Venrock Healthcare Capital Partners III LPBong KohVHCP CoInvestment Holdings III LLCVHCP Management III LLCVHCP Management EG LLCVenrock Healthcare Capital Partners EG LPNimish Shah | 10% OWNER | 88.10K | $14.47 | $1.27M | BUY | 1.89% | 4.74M | Jan 30 | View |
| Jan 29, 2024 | Venrock Healthcare Capital Partners III LPBong KohVHCP CoInvestment Holdings III LLCVHCP Management III LLCVHCP Management EG LLCVenrock Healthcare Capital Partners EG LPNimish Shah | 10% OWNER | 91.80K | $14.05 | $1.29M | BUY | 2.01% | 4.65M | Jan 25 - Jan 29 | View |
| Jan 24, 2024 | Venrock Healthcare Capital Partners III LPBong KohVHCP CoInvestment Holdings III LLCVHCP Management III LLCVHCP Management EG LLCVenrock Healthcare Capital Partners EG LPNimish Shah | 10% OWNER | 99.13K | $12.53 | $1.24M | BUY | 2.22% | 4.56M | Jan 22 - Jan 24 | View |
| Jan 19, 2024 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners EG LPVHCP Management EG LLCBong KohNimish Shah | 10% OWNER | 143.60K | $12.55 | $1.80M | BUY | 3.33% | 4.46M | Jan 17 - Jan 19 | View |
| Jan 16, 2024 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners EG LPVHCP Management EG LLCBong KohNimish Shah | 10% OWNER | 26.25K | $12.72 | $333.78K | BUY | 0.61% | 4.32M | Jan 11 - Jan 16 | View |
| Jan 12, 2024 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -22.68K | $13.03 | -$295.51K | SELL | -36.28% | 39.83K | Jan 11 | View |
| Jan 10, 2024 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners EG LPVHCP Management EG LLCBong KohNimish Shah | 10% OWNER | 137.70K | $12.54 | $1.73M | BUY | 3.32% | 4.29M | Jan 08 - Jan 10 | View |
| Jan 10, 2024 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -17.32K | $13.01 | -$225.30K | SELL | -21.70% | 62.51K | Jan 08 - Jan 09 | View |
| Jan 05, 2024 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners EG LPVHCP Management EG LLCBong KohNimish Shah | 10% OWNER | 59.37K | $12.14 | $720.54K | BUY | 1.45% | 4.15M | Jan 03 - Jan 04 | View |
| Dec 29, 2023 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners EG LPVHCP Management EG LLCBong KohNimish Shah | 10% OWNER | 519.02K | $12.46 | $6.47M | BUY | 14.52% | 4.09M | Dec 27 - Dec 29 | View |
| Dec 28, 2023 | Andrew Thomas Crockett | CEO | -30.00K | $12.02 | -$360.45K | SELL | -19.04% | 127.53K | Dec 27 | View |
| Nov 21, 2023 | Paul Audhya | CHIEF MEDICAL OFFICER | 10.54K | $8.23 | -$65.71K | SELL-OPTIONS | 40.52% | 36.57K | Nov 17 - Nov 20 | View |
| Nov 21, 2023 | Edward Feener | CHIEF SCIENTIFIC OFFICER | 6.54K | $8.23 | -$40.80K | SELL-OPTIONS | 8.92% | 79.83K | Nov 17 - Nov 20 | View |
| Nov 21, 2023 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 4.38K | $8.23 | -$58.54K | SELL-OPTIONS | 10.52% | 46.05K | Nov 17 - Nov 20 | View |
| Nov 21, 2023 | Benjamin L Palleiko | PRESIDENT, CFO, CBO & SEC'Y | 17.19K | $8.23 | -$107.05K | SELL-OPTIONS | 18.05% | 112.44K | Nov 17 - Nov 20 | View |
| Nov 21, 2023 | Andrew Thomas Crockett | CEO | 18.78K | $8.23 | -$121.85K | SELL-OPTIONS | 13.53% | 157.53K | Nov 17 - Nov 20 | View |
| Sep 13, 2023 | Albert Cha | DIRECTOR | 0.00 | $9.00 | -$54.23K | SELL-OPTIONS | 0.00% | 0.00 | Sep 11 | View |
| Aug 21, 2023 | Paul Audhya | CHIEF MEDICAL OFFICER | 10.51K | $10.73 | -$86.04K | SELL-OPTIONS | 67.74% | 26.02K | Aug 17 - Aug 18 | View |
| Aug 21, 2023 | Edward Feener | CHIEF SCIENTIFIC OFFICER | 6.52K | $10.73 | -$53.39K | SELL-OPTIONS | 9.76% | 73.29K | Aug 17 - Aug 18 | View |
| Aug 21, 2023 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 4.35K | $10.73 | -$76.62K | SELL-OPTIONS | 11.66% | 41.66K | Aug 17 - Aug 18 | View |
| Aug 21, 2023 | Benjamin L Palleiko | PRESIDENT, CFO, CBO & SEC'Y | 17.13K | $10.73 | -$140.19K | SELL-OPTIONS | 21.92% | 95.25K | Aug 17 - Aug 18 | View |
| Aug 21, 2023 | Andrew Thomas Crockett | CEO | 18.71K | $10.73 | -$159.60K | SELL-OPTIONS | 14.61% | 146.76K | Aug 17 - Aug 18 | View |
| May 19, 2023 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 1.60K | $10.14 | -$26.42K | SELL-OPTIONS | 4.48% | 37.31K | May 17 - May 18 | View |
| May 19, 2023 | Benjamin L Palleiko | PRESIDENT, CFO, CBO & SEC'Y | 5.33K | $10.14 | -$40.95K | SELL-OPTIONS | 7.32% | 78.13K | May 17 - May 18 | View |
| May 19, 2023 | Edward Feener | CHIEF SCIENTIFIC OFFICER | 2.42K | $10.14 | -$18.12K | SELL-OPTIONS | 3.76% | 66.77K | May 17 - May 18 | View |
| May 19, 2023 | Andrew Thomas Crockett | CEO | 7.12K | $10.14 | -$57.08K | SELL-OPTIONS | 5.89% | 128.05K | May 17 - May 18 | View |
| May 19, 2023 | Paul Audhya | CHIEF MEDICAL OFFICER | 3.67K | $10.14 | -$28.20K | SELL-OPTIONS | 39.23% | 13.01K | May 17 - May 18 | View |
| Feb 23, 2023 | Paul Audhya | CHIEF MEDICAL OFFICER | 3.03K | $7.66 | -$26.14K | SELL-OPTIONS | 48.06% | 9.35K | Feb 17 | View |
| Feb 23, 2023 | Edward Feener | CHIEF SCIENTIFIC OFFICER | 1.98K | $7.66 | -$17.07K | SELL-OPTIONS | 3.17% | 64.35K | Feb 17 | View |
| Feb 23, 2023 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 1.48K | $7.66 | -$20.89K | SELL-OPTIONS | 4.31% | 35.71K | Feb 17 | View |
| Feb 23, 2023 | Benjamin L Palleiko | PRESIDENT, CFO, CBO & SEC'Y | 4.41K | $7.66 | -$37.95K | SELL-OPTIONS | 6.45% | 72.80K | Feb 17 | View |
| Feb 23, 2023 | Andrew Thomas Crockett | CEO | 6.05K | $7.66 | -$51.32K | SELL-OPTIONS | 5.27% | 120.93K | Feb 17 | View |
| Nov 21, 2022 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 635.00 | $5.44 | -$6.20K | SELL-OPTIONS | 1.89% | 34.23K | Nov 17 - Nov 18 | View |
| Nov 21, 2022 | Benjamin L Palleiko | CFO, CBO & SECRETARY | 1.70K | $5.44 | -$3.93K | SELL-OPTIONS | 2.54% | 68.39K | Nov 17 - Nov 18 | View |
| Nov 21, 2022 | Edward Feener | CHIEF SCIENTIFIC OFFICER | 1.24K | $5.44 | -$2.88K | SELL-OPTIONS | 2.03% | 62.38K | Nov 17 - Nov 18 | View |
| Nov 21, 2022 | Andrew Thomas Crockett | CEO | 4.02K | $5.44 | -$9.71K | SELL-OPTIONS | 3.63% | 114.88K | Nov 17 - Nov 18 | View |
| Nov 21, 2022 | Paul Audhya | CHIEF MEDICAL OFFICER | 1.70K | $5.44 | -$3.93K | SELL-OPTIONS | 39.94% | 5.95K | Nov 17 - Nov 18 | View |
| Sep 07, 2022 | Andrew Thomas Crockett | CEO | -7.82K | $17.01 | -$22.46K | SELL | -6.59% | 110.86K | Jul 02 - Sep 02 | View |
| Aug 19, 2022 | Paul Audhya | CHIEF MEDICAL OFFICER | 1.69K | $14.96 | -$10.85K | SELL-OPTIONS | ∞ | 1.69K | Aug 17 | View |
| Aug 19, 2022 | Edward Feener | CHIEF SCIENTIFIC OFFICER | 1.24K | $14.96 | -$7.96K | SELL-OPTIONS | 2.07% | 61.13K | Aug 17 | View |
| Aug 19, 2022 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 628.00 | $14.96 | -$17.13K | SELL-OPTIONS | 1.90% | 33.60K | Aug 17 | View |
| Aug 19, 2022 | Benjamin L Palleiko | CFO, CBO & SECRETARY | 1.69K | $14.96 | -$10.85K | SELL-OPTIONS | 2.60% | 66.69K | Aug 17 | View |
| Aug 19, 2022 | Andrew Thomas Crockett | CEO | 4.01K | $14.96 | -$26.89K | SELL-OPTIONS | 3.71% | 112.18K | Aug 17 | View |
| Mar 11, 2022 | Andrew Thomas Crockett | CEO | -10.00K | $17.07 | -$170.69K | SELL | -8.02% | 114.67K | Mar 09 | View |
| Nov 03, 2021 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -6.00K | $18.07 | -$108.42K | SELL | -72.87% | 2.23K | Nov 01 | View |
| Nov 03, 2021 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | -5.00K | $18.07 | -$90.33K | SELL | -13.17% | 32.97K | Nov 01 | View |
| Oct 04, 2021 | Andrew Thomas Crockett | CEO | -10.00K | $17.18 | -$171.84K | SELL | -7.43% | 124.67K | Oct 01 | View |
| Aug 04, 2021 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | -5.00K | $20.52 | -$102.58K | SELL | -11.64% | 37.97K | Aug 02 | View |
| Aug 04, 2021 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -6.00K | $20.52 | -$123.13K | SELL | -42.15% | 8.23K | Aug 02 | View |
| Jul 02, 2021 | Andrew Thomas Crockett | CEO | -10.00K | $24.15 | -$241.48K | SELL | -6.91% | 134.67K | Jul 01 | View |
| Jun 22, 2021 | Andrew Thomas Crockett | CEO | -1.07K | $30.04 | -$32.05K | SELL | -0.73% | 144.67K | Jun 17 | View |
| Jun 11, 2021 | Andrew Thomas Crockett | CEO | -8.93K | $30.05 | -$268.48K | SELL | -5.78% | 145.74K | Jun 09 | View |
| Jun 03, 2021 | David Michael Smith | SENIOR VP, DEVELOPMENT | 0.00 | $17.61 | -$138.30K | SELL-OPTIONS | 0.00% | 0.00 | Jun 01 | View |
| Jun 03, 2021 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -34.00K | $26.72 | -$908.36K | SELL | -70.49% | 14.23K | Jun 01 - Jun 02 | View |
| May 06, 2021 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | -5.00K | $24.84 | -$124.20K | SELL | -10.42% | 42.97K | May 03 | View |
| May 06, 2021 | Edward Feener | CHIEF SCIENTIFIC OFFICER | 0.00 | $17.53 | -$87.79K | SELL-OPTIONS | 0.00% | 54.23K | May 03 | View |
| Apr 30, 2021 | David Michael Smith | SENIOR VP, DEVELOPMENT | 0.00 | $17.08 | -$173.97K | SELL-OPTIONS | 0.00% | 0.00 | Apr 28 | View |
| Apr 29, 2021 | Andreas Maetzel | SENIOR VICE PRESIDENT, MEDICAL | 0.00 | $17.24 | -$1.42M | SELL-OPTIONS | 0.00% | 0.00 | Apr 27 - Apr 29 | View |
| Apr 05, 2021 | Andrew Thomas Crockett | CEO | -10.00K | $27.44 | -$274.44K | SELL | -5.90% | 159.42K | Apr 01 | View |
| Feb 25, 2021 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | -15.00K | $33.59 | -$503.88K | SELL | -23.82% | 47.97K | Feb 23 | View |
| Feb 25, 2021 | Benjamin L Palleiko | CFO, CBO & SECRETARY | 0.00 | $20.16 | -$795.77K | SELL-OPTIONS | 0.00% | 65.00K | Feb 23 | View |
| Feb 25, 2021 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -31.00K | $33.60 | -$1.04M | SELL | -36.37% | 54.23K | Feb 23 | View |
| Feb 25, 2021 | Andrew Thomas Crockett | CEO | -10.00K | $33.55 | -$335.54K | SELL | -5.57% | 169.42K | Feb 23 | View |
| Jan 06, 2021 | Andrew Thomas Crockett | CEO | -16.00K | $18.19 | -$181.90K | SELL | -8.19% | 179.42K | Oct 29 - Jan 04 | View |
| Jan 04, 2021 | Benjamin L Palleiko | CFO, CBO & SECRETARY | 0.00 | $13.39 | -$4.76K | SELL-OPTIONS | 0.00% | 32.50K | Dec 30 | View |
| Nov 04, 2020 | Edward Feener | — | -6.00K | $17.14 | -$102.81K | SELL | -7.62% | 72.73K | Nov 02 | View |
| Nov 03, 2020 | Albert Cha | — | 115.69K | $17.24 | $1.99M | PURCHASE | 11.31% | 1.14M | Oct 30 | View |
| Nov 02, 2020 | Christopher Yea | — | -5.00K | $17.48 | -$87.39K | SELL | -7.36% | 62.97K | Oct 29 | View |
| Oct 22, 2020 | Christopher Yea | — | -13.99K | $17.82 | -$249.17K | SELL | -17.07% | 67.97K | Oct 20 - Oct 21 | View |
| Oct 22, 2020 | Edward Feener | — | -16.91K | $17.92 | -$303.02K | SELL | -17.68% | 78.73K | Oct 20 - Oct 21 | View |
| Oct 22, 2020 | Andrew Thomas Crockett | — | -38.54K | $17.98 | -$693.03K | SELL | -16.47% | 195.42K | Oct 20 - Oct 21 | View |
| Oct 20, 2020 | Christopher Yea | — | -914.00 | $17.00 | -$15.54K | SELL | -1.10% | 81.95K | Oct 16 | View |
| Oct 20, 2020 | Edward Feener | — | -993.00 | $17.00 | -$16.88K | SELL | -1.03% | 95.64K | Oct 16 | View |
| Oct 20, 2020 | Andrew Thomas Crockett | — | -4.26K | $17.01 | -$21.44K | GIFT | -1.79% | 233.96K | Apr 29 - Oct 16 | View |
| Feb 07, 2020 | Christopher Yea | — | -100.00 | $17.10 | -$1.71K | SELL | -0.12% | 82.87K | Feb 05 | View |
| Feb 07, 2020 | Edward Feener | — | -100.00 | $17.11 | -$1.71K | SELL | -0.10% | 96.63K | Feb 05 | View |
| Feb 07, 2020 | Andrew Thomas Crockett | — | -200.00 | $17.05 | -$3.41K | SELL | -0.08% | 238.22K | Feb 05 | View |
| Dec 26, 2019 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 0.00 | $8.51 | -$45.01K | SELL-OPTIONS | 0.00% | 82.97K | Dec 20 | View |
| Dec 26, 2019 | Andrew Thomas Crockett | CEO | -2.30K | $17.02 | -$39.15K | SELL | -0.96% | 238.42K | Dec 20 | View |
| Dec 16, 2019 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 0.00 | $8.53 | -$80.25K | SELL-OPTIONS | 0.00% | 82.97K | Dec 12 - Dec 16 | View |
| Dec 16, 2019 | Andrew Thomas Crockett | CEO | -7.70K | $17.06 | -$131.35K | SELL | -3.10% | 240.72K | Dec 12 - Dec 16 | View |
| Sep 30, 2019 | DANIEL SOLAND | DIRECTOR | 10.00K | $11.87 | $118.75K | BUY | ∞ | 10.00K | Sep 26 - Sep 27 | View |
| Jul 30, 2019 | Albert Cha | DIRECTOR | 56.37K | $16.99 | $957.74K | BUY | 82.65% | 124.57K | Jul 26 - Jul 29 | View |
| Jul 24, 2019 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 0.00 | $9.17 | -$134.90K | SELL-OPTIONS | 0.00% | 82.97K | Jul 22 | View |
| Jul 24, 2019 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -3.30K | $18.62 | -$61.44K | SELL | -3.30% | 96.73K | Jul 22 - Jul 23 | View |
| Jul 19, 2019 | Albert Cha | DIRECTOR | 61.28K | $17.79 | $1.09M | BUY | 4.92% | 1.31M | Jul 17 - Jul 19 | View |
| Jul 17, 2019 | Andrew Thomas Crockett | CEO | -10.00K | $17.04 | -$170.41K | SELL | -3.87% | 248.51K | Jul 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.